Form4insider filings, from the source

SEC Form 4 · accession 0001676051-16-000004

Cellectar Biosciences, Inc. · CLRB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Apr 15, 2016
Accepted (ET)
Jun 14, 2016 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Cellectar Biosciences, Inc. (CLRB) Common StockApr 15, 2016P234,742$2.12A297,242D
Cellectar Biosciences, Inc.Apr 21, 2016P3,758$1.90A301,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Cellectar Biosciences, Inc. Series A Warrant (CLRBZ)F2,F1$3.04Apr 15, 2016P234,742AApr 20, 2016Apr 20, 2021Cellectar Biosciences, Inc. (CLRB) Common Stock234,74241,915D

Explanation of responses